NEW AGE FOR NUCLEAR MEDICINE
Radioactive drugs are not just diagnosing disease more effectively, they’re now being used for exciting new therapies. They could be revolutionary in fighting cancer in the 21st century, says Sandy McEwan, vice president of radiopharmaceuticals at Ipsen.
Recent News
James Lind Alliance (JLA) Priority Setting Partnership (PSP) in Neuroendocrine Cancer
We are delighted to announce the launch of a James Lind Alliance (JLA) Priority Setting Partnership (PSP) in Neuroendocrine Cancer, jointly led by UKINETS and Neuroendocrine Cancer UK. This important national initiative aims to identify and prioritise the most...
Upcoming Nurse Webinar – 17th September 8am
Calling All Nurses: Join the Will Norman Nurse Webinar on Neuroendocrine Cancer
Join us on 17th September at 8am GMT for a free, online educational webinar focused on Neuroendocrine Cancer, brought to you in collaboration with NeuroEndocrine Cancer Australia, Neuroendocrine Cancer UK, and NeuroEndocrine Cancer New Zealand. This 2-hour session includes expert-led presentations and a live Q&A roundtable. Open to nurses only. Register now to secure your place!
Neuroendocrine Cancer UK Working with National Disease Registration Service – Get Data Out
Get Data Out We are delighted to announce that we are working, alongside neuroendocrine cancer expert clinicians, with the National Disease Registration Service (NDRS) Get Data Out programme team, to add neuroendocrine cancers to the list of cancers the NDRS...